By Serena McNiff
Whereas it is not clear exactly how SARS-CoV-2 causes clots, a brand new research means that the quantity of a specific protein — referred to as issue V — in a affected person’s blood might have one thing to do with it.
In March, researchers at Massachusetts Normal Hospital obtained a blood pattern from a affected person with extreme COVID-19 and seen one thing uncommon. The affected person’s blood had considerably above-normal ranges of issue V.
Researchers then studied greater than 100 sufferers handled within the intensive care unit for COVID-19.
Excessive ranges of issue V had been discovered throughout the group, and almost half of the sufferers had above-normal ranges. When researchers in contrast the samples to historic data, greater than 1 in 10 sufferers had increased issue V ranges than had been seen earlier than on the hospital.
“Other than COVID-19, I’ve by no means seen the rest trigger markedly elevated issue V, and I have been doing this for 25 years,” research co-author Dr. Elizabeth Van Cott stated in a hospital information launch. She is a pathology investigator at Mass Normal and a pathology professor at Harvard Medical Faculty.
The research discovered that sufferers with elevated issue V had been extra more likely to have blood clots within the lungs, referred to as pulmonary embolism, and deep vein thrombosis (DVT), or clots within the veins.
Of sufferers with excessive ranges of issue V, one-third had both DVT or a pulmonary embolism, in contrast with 13% of sufferers with decrease ranges.
Whereas sufferers with excessive issue V ranges had been at larger threat for clotting issues, sufferers with decrease issue V ranges had a better threat of loss of life, researchers discovered.
A lower in issue V ranges would possibly point out sufferers are progressing to a severe and infrequently deadly situation by which clotting processes develop into overactive, Van Cott and colleagues stated.
They stated the findings may assist determine which sufferers are at elevated threat of blood clots and loss of life.
The findings had been just lately printed on-line within the American Journal of Hematology.